Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases

Abstract

Introduction: Pathologic apoptosis is described in IPF. Macrophage activation is implicated in the pathogenesis of fibrotic lung diseases. The apoptotic profile of alveolar macrophages (AM) in IPF is unclear.
Aim: To examine the expression of apoptotic proteins in AM of patients with IPF after therapeutic intervention.
Methods: Twenty newly diagnosed IPF patients were randomised in group A treated by a combination of interferonγ-1b and prednisolone and group B treated by azathioprine and prednisolone. Groups were compared regarding clinical deterioration, lung function, and bronchoalveolar lavage (BAL) apoptosis markers.
We analyzed by immunohistochemistry, the expression of the anti- apoptotic markers bcl-2 and the pro-apoptotic markers bax, fas, fas ligand in AM obtained from BAL before and after treatment. We measured apoptosis by TUNEL.
Immunohistochemistry results were evaluated with a digital image analysis assay.
Results: No difference was observed regarding age, gender, smoking habit between the two groups of IPF patients. The patients of both groups had similar FEV1, FVC and DLCO values at entry and after six months of treatment.
We found no difference in the expression of apoptotic markers in AMs before and after treatment between groups. We found no correlation between clinical and functional parameters and change in apoptotic markers.
Conclusions: We specifically examined the expression of apoptotic markers in AMs of patients with IPF and we report that different treatment options do not affect the expression of these markers in IPF. These results may be related to the ineffectiveness of pharmacological therapies for IPF.

Rating:

Share or cite this content

Citations should be made in the following way:
F. Drakopanagiotakis, A. Xyfteri, E. Tsiambas, G. Vilaras, A. Karameris, C. Tsakanika, V. Polychronopoulos, D. Bouros (Athens, Alexandroupoli, Greece). Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF. Eur Respir J 2011; 38: Suppl. 55, 4777

Member's Comments

No comment yet.

Related content which might interest you: CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007 Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 No evidence of corticosteroid resistance in COPD alveolar macrophages Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 PD-L1 expression on alveolar macrophages and in plasma of IPF patients – original research Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011 Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 IFNγ induces steroid unresponsiveness in smokers alveolar macrophages Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019